Rational supportive therapy for chemotherapy induced anemia: A pharmaco-economic analysis of erythropoietin therapy in cancer patients in Russian...
Ларионова В. Б., Крyсанов И. С., Снеговоy А. В., Зеиналова П. А., Крысанова В. С., Ермакова В. Ю.
Онкогематология
Т. 13, Вып. 2, С. 48-61
Опубликовано: 2018
Тип ресурса: Статья
DOI:10.17650/1818-8346-2018-13-2-48-61
Аннотация:
Modern anticancer therapy due to its intensity and molecular biology orientation allows achieving higher efficiency and theoretically reducing the incidence of complications. However, the increase in efficacy in the modern oncology really exists, but reducing complication frequency, unfortunately, is far from being solved. In many respects the problems of diagnosis, treatment and complications monitoring are associated with the impact on the complex physiological processes occurring in oncological patient. Timely implementation of modern and adequate programs for the prevention and treatment of these complications defines the concept of "supportive therapy", which provides at least half the effectiveness of antitumor treatment. To date, according to most studies, the most frequent complications of antitumor therapy are hematologic, in particular - anemia. In clinical practice, blood transfusions, recombinant human erythropoietins, hemopoiesis stimulating cofactors are used to correct t
Ключевые слова:
"cost minimization" analysis; Anemia; Darbepoetin alfa; Epoetin alfa; Erythropoietin; Non-myeloid malignancies; Pharmaco-economic analysis; Pharmacoeconomics; Supportive care
Язык текста: Русский
ISSN: 2413-4023
Ларионова В. Б.
Крyсанов И. С.
Снеговоy А. В.
Зеиналова П. А.
Крысанова В. С. Вера Сергеевна 1991-
Ермакова В. Ю. Виктория Юрьевна 1983-
Larionova V. B.
Krysanov I. S.
Snegovoy A. V.
Zeinalova P. A.
Kry'sanova V. S. Vera Sergeevna 1991-
Ermakova V. Yu. Viktoriya Yuryevna 1983-
Rational supportive therapy for chemotherapy induced anemia: A pharmaco-economic analysis of erythropoietin therapy in cancer patients in Russian Federation
Rational supportive therapy for chemotherapy induced anemia: A pharmaco-economic analysis of erythropoietin therapy in cancer patients in Russian...
Текст визуальный непосредственный
Онкогематология
Издательский дом "АБВ-пресс"
Т. 13, Вып. 2 С. 48-61
2018
Статья
"cost minimization" analysis Anemia Darbepoetin alfa Epoetin alfa Erythropoietin Non-myeloid malignancies Pharmaco-economic analysis Pharmacoeconomics Supportive care
Modern anticancer therapy due to its intensity and molecular biology orientation allows achieving higher efficiency and theoretically reducing the incidence of complications. However, the increase in efficacy in the modern oncology really exists, but reducing complication frequency, unfortunately, is far from being solved. In many respects the problems of diagnosis, treatment and complications monitoring are associated with the impact on the complex physiological processes occurring in oncological patient. Timely implementation of modern and adequate programs for the prevention and treatment of these complications defines the concept of "supportive therapy", which provides at least half the effectiveness of antitumor treatment. To date, according to most studies, the most frequent complications of antitumor therapy are hematologic, in particular - anemia. In clinical practice, blood transfusions, recombinant human erythropoietins, hemopoiesis stimulating cofactors are used to correct t